|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K 14/55 | (2006.01) | ||
| A61K 47/68 | (2017.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61P 35/04 | (2006.01) |
| (11) | Number of the document | 3150218 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16195608.1 |
| Date of filing the European patent application | 2008-09-19 | |
| (97) | Date of publication of the European application | 2017-04-05 |
| (45) | Date of publication and mention of the grant of the patent | 2021-09-08 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 994717 P | 2007-09-21 | US |
| (72) |
Morrison, Sherie L. , US
Huang, Tzu-Hsuan , US
Xuan, Caiyun , US
|
| (73) |
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA ,
1111 Franklin Street, 12th Floor, Oakland, CA 94607-5200,
US
|
| (54) | TARGETED INTERFERON DEMONSTRATES POTENT APOPTOTIC AND ANTI-TUMOR ACTIVITIES |
| TARGETED INTERFERON DEMONSTRATES POTENT APOPTOTIC AND ANTI-TUMOR ACTIVITIES |